Envestnet Asset Management Inc. Decreases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Envestnet Asset Management Inc. reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 78.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 306,254 shares of the pharmaceutical company’s stock after selling 1,145,620 shares during the period. Envestnet Asset […]
More Stories
Mizuho Issues Pessimistic Forecast for Valero Energy (NYSE:VLO) Stock Price
Valero Energy (NYSE:VLO – Get Free Report) had its price target dropped by Mizuho from $165.00 to $158.00 in a...
Morgan Stanley Forecasts Strong Price Appreciation for Carnival Co. & (NYSE:CCL) Stock
Carnival Co. & (NYSE:CCL – Get Free Report) had its target price lifted by investment analysts at Morgan Stanley from...
Regency Centers (NASDAQ:REG) Price Target Raised to $80.00 at Mizuho
Regency Centers (NASDAQ:REG – Get Free Report) had its target price boosted by research analysts at Mizuho from $78.00 to...
Two Harbors Investment (NYSE:TWO) Hits New 52-Week Low – What’s Next?
Two Harbors Investment Corp. (NYSE:TWO – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday...
Boston Scientific (NYSE:BSX) Shares Gap Up – Should You Buy?
Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) gapped up before the market opened on Wednesday . The...
Sturm, Ruger & Company, Inc. (NYSE:RGR) Reaches New 52-Week Low – What’s Next?
Sturm, Ruger & Company, Inc. (NYSE:RGR – Get Free Report)’s share price reached a new 52-week low during mid-day trading...